Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

Running, not enrolling · Phase 3 · Has a placebo group

Conditions studied: Immunoglobulin A Nephropathy

In brief

The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserving renal function.

Key facts

Study ID
NCT06564142
Run by
Alpine Immune Sciences Inc, A Subsidiary of Vertex
People needed
605
Starts
2024-08-30
Expected to finish
2028-01-30
Last updated by the study team
2026-05-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.